Credits Available: 4.75 hours of AMA PRA Category 1 Credit™ with ABIM MOC

Description: This curriculum is designed to enhance knowledge, competence, and confidence among oncology clinicians regarding second-line therapy for small cell lung cancer (SCLC). Learners will explore evidence-based treatment sequencing, adverse event management, and emerging clinical trial data to optimize patient outcomes.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Physician Associate/Assistant
Target Specialties: Oncology, Hematology/Oncology

Robert Merritt

The Ohio State University

I am a general thoracic surgeon with expertise in minimally invasive surgery in the treatment of lung and esophageal cancers. My clinical interests include primary lung carcinoma, esophageal carcinoma, thymic malignancies, primary tumors of the chest wall, tracheal tumors and secondary lung carcinoma. I also serve as professor and director of the Division of Thoracic Surgery at The Ohio State University, as well as director of inpatient services at The James. I was named to the Castle Connolly list of “Regional Top Doctors” from 2017-2019 and rated in the top 10 percent of physicians in the nation for patient satisfaction in 2015.